Chicago-based Meitheal Pharmaceuticals, along with its Chinese parent, was busy in 2024, adding both biosimilar drugs and ...

A Virginia pharmacy owner will serve jail time for a generic medication scheme that caused $1.3 million in losses to the government, federal officials said. Randy Yost, 72, who owns Randy’s Gateway ...

Despite weathering significant criticism from lawmakers and patient groups over the steep cost of its rare disease med ...

CVS' Aetna sues drug manufacturers for price-fixing and market allocation scheme. The subsidiary seeks damages and ...

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

With multiple stakeholders involved with different interests, the “specialty drug” definition can be a moving target.

Healey plans to host a ceremony at 11 a.m. Wednesday with legislative leaders to sign both the prescription drug bill and a ...

The national group representing generic drug and biosimilar manufacturers is looking to replicate its success challenging ...

New research from University of Iowa dispels the belief that pharmaceutical mergers lead to higher drug prices, showing a decrease in prices for generic drugs.

The bill would add scrutiny to pharmacy benefit managers and eliminate or cap out-of-pocket costs for drugs that treat ...